Sign up to save your podcasts
Or
Share AI-Powered Pharma - Strategic Imperatives for Executive Leadership in 2025
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
AI-Powered Pharma - Strategic Imperatives for Executive Leadership in 2025
The AI revolution in pharma has reached an inflection point—what was once experimental is now the strategic imperative for survival and growth. In this episode, we explore how forward-thinking executives are harnessing AI to redefine drug discovery, manufacturing, and supply chains while navigating regulatory complexity and organizational transformation.
Key Discussion Points:
With the AI-driven drug discovery market exploding from $1.5B to $15.5B by 2032, leaders who delay risk irrelevance—while those who act gain first-mover advantage in precision medicine and patient-centric care.
Who Should Listen?
C-suite executives, digital transformation leaders, and manufacturing heads preparing for AI-at-scale. Whether you’re assessing organizational readiness or prioritizing high-ROI use cases, this episode delivers a clear roadmap to lead—not follow—the AI revolution.
Tune in to future-proof your organization and turn AI potential into measurable impact!
Resources:
Book Series: Center of Excellence – Pharma 4.0 https://www.amazon.com/dp/B0F1DX4XXB
Udemy Course: Smart Manufacturing in Pharma https://www.udemy.com/course/smart-manufacturing-in-pharma/
Subscribe to our YouTube channel https://www.youtube.com/@COE-PHARMA4.0
Website: https://respa.com
and follow the Podcast https://pharma4coe.podbean.com for more insights on the future of Pharma!
#Pharma40 #DigitalSupplyChain #AIinPharma #IoT #Robotics #DigitalTransformation #SupplyChainInnovation #Podcast #ArtificialIntelligence #AI #PharmaceuticalIndustry #Innovation #Pharma
View all episodes
By Dr. Jayant JoshiThe AI revolution in pharma has reached an inflection point—what was once experimental is now the strategic imperative for survival and growth. In this episode, we explore how forward-thinking executives are harnessing AI to redefine drug discovery, manufacturing, and supply chains while navigating regulatory complexity and organizational transformation.
Key Discussion Points:
With the AI-driven drug discovery market exploding from $1.5B to $15.5B by 2032, leaders who delay risk irrelevance—while those who act gain first-mover advantage in precision medicine and patient-centric care.
Who Should Listen?
C-suite executives, digital transformation leaders, and manufacturing heads preparing for AI-at-scale. Whether you’re assessing organizational readiness or prioritizing high-ROI use cases, this episode delivers a clear roadmap to lead—not follow—the AI revolution.
Tune in to future-proof your organization and turn AI potential into measurable impact!
Resources:
Book Series: Center of Excellence – Pharma 4.0 https://www.amazon.com/dp/B0F1DX4XXB
Udemy Course: Smart Manufacturing in Pharma https://www.udemy.com/course/smart-manufacturing-in-pharma/
Subscribe to our YouTube channel https://www.youtube.com/@COE-PHARMA4.0
Website: https://respa.com
and follow the Podcast https://pharma4coe.podbean.com for more insights on the future of Pharma!
#Pharma40 #DigitalSupplyChain #AIinPharma #IoT #Robotics #DigitalTransformation #SupplyChainInnovation #Podcast #ArtificialIntelligence #AI #PharmaceuticalIndustry #Innovation #Pharma